Xinbang Pharmaceutical: Net profit in 2025 is 120 million yuan, a year-on-year increase of 18.65%.

Sinopharm Pharmaceutical announced that the operating income in 2025 was 5.62 billion yuan, a year-on-year decrease of 6.84%. Net profit was 120 million yuan, an increase of 18.65% year-on-year. The profit distribution plan approved by the board of directors for this year is as follows: based on a total share capital of 1.944 billion shares after deducting 47.4455 million shares repurchased by the company's repurchase special securities account, a cash dividend of 0.6 yuan will be distributed to all shareholders for every 10 shares, no bonus shares will be issued, and no increase in capital from the surplus reserve will be made.